metoclopramide has been researched along with cabergoline in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Baroldi, P; Cammelli, L; Pontiroli, AE; Pozza, G | 1 |
| Beyerbach, M; Eschricht, F; Günzel-Apel, AR; Hoppen, HO; Koivisto, MB; Oei, CH; Urhausen, C | 1 |
| Du, Y; Lin, XM; Ma, YS; Ni, J; Tang, YY; Zhou, J | 1 |
1 review(s) available for metoclopramide and cabergoline
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for metoclopramide and cabergoline
| Article | Year |
|---|---|
Effects of short-term hyper- and hypoprolactinaemia on hormones of the pituitary, gonad and -thyroid axis and on semen quality in male Beagles.
Topics: Animals; Cabergoline; Dogs; Dopamine Agonists; Dopamine Antagonists; Ergolines; Luteinizing Hormone; Male; Metoclopramide; Pituitary Gland; Prolactin; Semen; Testis; Testosterone; Thyroid Gland; Thyrotropin; Thyrotropin-Releasing Hormone; Thyroxine | 2009 |
4 other study(ies) available for metoclopramide and cabergoline
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Inhibition of basal and metoclopramide-induced prolactin release by cabergoline, an extremely long-acting dopaminergic drug.
Topics: Adult; Cabergoline; Dopamine; Ergolines; Humans; Male; Metoclopramide; Prolactin; Stimulation, Chemical; Time Factors | 1987 |
Relaxant effects of metoclopramide and magnesium sulfate on isolated pregnant myometrium: an in vitro study.
Topics: Adult; Cabergoline; Dopamine Agonists; Dopamine Antagonists; Ergolines; Female; Humans; In Vitro Techniques; Magnesium Sulfate; Metoclopramide; Muscle Relaxation; Myometrium; Oxytocin; Pregnancy; Tocolytic Agents; Uterine Contraction | 2014 |